Zevra Therapeutics Inc (ZVRA)

Cash & Equivalents

$145.32M

Quarterly · Period ending: · USD

ZVRA logo

ZVRA Cash & Equivalents

Latest reported$145.32M
ZVRA Quarterly Cash & Equivalents ($1.97M → $145.32M)
High-resolution chart · PNG

ZVRA cash & equivalents history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Zevra Therapeutics Inc Cash & Equivalents — Quarterly (USD)
Period endingCash & Equivalents (USD)
145,321,000
95,595,000
62,406,000
54,439,000
47,712,000
37,340,000
33,785,000
54,039,000
39,260,000
42,849,000
43,049,000
43,269,000
66,196,000
40,181,000
65,466,000
70,059,000
76,779,000
100,242,000
112,346,000
131,503,000
132,295,000
75,917,000
4,213,000
5,267,000
6,369,000
2,356,000
3,217,000
6,518,000
7,308,000
13,438,000
18,409,000
1,788,000
16,497,000
8,750,000
10,871,000
7,829,000
12,386,000
12,880,000
16,762,000
20,846,000
27,510,000
77,333,000
32,318,000
59,009,000
64,223,000
10,269,000
10,255,021
19,022,563
-1,968,633
1,968,632
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.